The Joint Commission’s brain tumor care certification is part of the organization’s broader disease-specific-care certification program, which launched in 2002. Under it, hospitals and health systems can apply for certification across multiple conditions or chronic diseases. The brain tumor certification falls under its hematology/oncology certification category.
Recipients must meet standards and adhere to criteria related to each certification and also undergo an on-site review, which evaluates the organization’s clinical outcomes, evidence-based guidelines within daily practices, performance metrics and care improvements, if leaders are involved in improving quality of care, and how patients are educated and prepared to discharge.
The seven hospitals certified in brain tumor care are:
- Chippenham and Johnston-Willis Hospital, Richmond, Va.
- Hackensack (N.J.) University Medical Center Hackensack
- Jewish Hospital, Cincinnati
- Pitt County Memorial Hospital, Greenville, N.C.
- Santa Barbara (Calif.) Cottage Hospital
- St. Vincent Hospital and Health Care Services, Indianapolis
- Texas Health Harris Methodist Hospital – Fort Worth
Disease-specific certifications are granted for a two-year period. Following that, a program must regularly re-apply and re-submit data for evaluation to The Joint Commission.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
